Compound class:
Synthetic organic
Comment: This compound (9d) is a SOS1-directed PROTAC [2]. It is a hybrid molecule combining a VHL ligand and a SOS1 agonist (from [1]). Although the SOS1-interacting part of this PROTAC is an agonist it mediates efficient SOS1 protein degradation. In vitro 9d provides antiproliferative activity against human cancer cells with various KRAS mutations, and it inhibits tumour growth in a xenograft mouse model.
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Bioactivity Comments |
9d degrades SOS1 protein by 92.5% at 1 μM [2], We obtained the binding affinity (Kd) value for the SOS1 agonist component of this PROTAC from Hodges et al. (2018) [1]. This value may be slightly altered by inclusion in the larger PROTAC molecule. |
Selectivity at other protein targets | ||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|